Results by title

4 books match the query 'Drug utilization'

cover of Acts of Resistance: Antibiotic Use and Prescribing Culture in the United States

Acts of Resistance

Antibiotic Use and Prescribing Culture in the United States

Katharina Rynkiewich

Vanderbilt University Press, 2026

In Acts of Resistance, Katharina Rynkiewich explores the fight to save the utility of antibiotic medicines amid global antimicrobial resistance. This engaging ethnography follows bacteria, patients, and practitioners as they weave in and out of North American medical institutions. Through an examination of the social dynamics and ethical challenges of everyday antibiotic use, the author expands on the limitations of good intentions in current antibiotic stewardship policy. Her ethnographic account shows the lived experience of multiple central figures as she shifts setting and tone, ultimately deepening our understanding of the global antimicrobial resistance crisis as emergency.

Due to the global scale of impact related to antimicrobial resistance, holding industries and institutions accountable is difficult but essential. With new and reemerging multidrug-resistant organisms making their homes within institutions and in the community, tracing the origins of an infection can be an insurmountable challenge. Rynkiewich demonstrates how “microbial highways” coexist along human highways, providing an apt example of how multidrug-resistant organisms spread across hospitals, communities, and entire regions.

[more]
cover of Drugs for Life: How Pharmaceutical Companies Define Our Health

Drugs for Life

How Pharmaceutical Companies Define Our Health

Joseph Dumit

Duke University Press, 2012

Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.
[more]
cover of Impotent: A Novel

Impotent

A Novel

Matthew Roberson

University of Alabama Press, 2009

Impotent is a collection of moving stories about a time when "it is easier to get a refill on a prescription than approval for therapy" and individuals are reduced to letters on a medical chart. In revealing vignettes, Matthew Roberson clinically catalogs the hopes, dreams, and failures of people identified only through form-like abbreviations (C— for co-dependent, I— for Insured). In these "case studies," Roberson captures his subjects' lives poignantly by supplementing their diagnoses with unconventional footnotes, lists, and medicinal warnings. Each vignette exposes a different facet of our medicated society, humanizing a multitude of conditions: depression, anxiety, obsessive-compulsive disorder, impotence, and dementia. In a world of domestic ennui, deadpan voices struggle to transcend numbness while simultaneously trying to manage the pain of living. Impotent is both important social commentary and engrossing fiction.

[more]
cover of The Cult of Pharmacology: How America Became the World's Most Troubled Drug Culture

The Cult of Pharmacology

How America Became the World's Most Troubled Drug Culture

Richard DeGrandpre

Duke University Press, 2006

America had a radically different relationship with drugs a century ago. Drug prohibitions were few, and while alcohol was considered a menace, the public regularly consumed substances that are widely demonized today. Heroin was marketed by Bayer Pharmaceuticals, and marijuana was available as a tincture of cannabis sold by Parke Davis and Company.

Exploring how this rather benign relationship with psychoactive drugs was transformed into one of confusion and chaos, The Cult of Pharmacology tells the dramatic story of how, as one legal drug after another fell from grace, new pharmaceutical substances took their place. Whether Valium or OxyContin at the pharmacy, cocaine or meth purchased on the street, or alcohol and tobacco from the corner store, drugs and drug use proliferated in twentieth-century America despite an escalating war on “drugs.”

Richard DeGrandpre, a past fellow of the National Institute on Drug Abuse and author of the best-selling book Ritalin Nation, delivers a remarkably original interpretation of drugs by examining the seductive but ill-fated belief that they are chemically predestined to be either good or evil. He argues that the determination to treat the medically sanctioned use of drugs such as Miltown or Seconal separately from the illicit use of substances like heroin or ecstasy has blinded America to how drugs are transformed by the manner in which a culture deals with them.

Bringing forth a wealth of scientific research showing the powerful influence of social and psychological factors on how the brain is affected by drugs, DeGrandpre demonstrates that psychoactive substances are not angels or demons irrespective of why, how, or by whom they are used. The Cult of Pharmacology is a bold and necessary new account of America’s complex relationship with drugs.

[more]